Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PSC-833 modulates the tumor disposition of vinca alkaloids in vitro and in vivo

Jan. 7, 1999

Angiogene's vascular-targeting agent for solid tumors enters Zeneca's development portfolio

Jan. 5, 1999

Expanded use of Photofrin approved by FDA

Jan. 4, 1999

Ajinomoto prepares potent, water-soluble combretastatin analogues

Dec. 30, 1998

IND filed by Cell Pathways for new SAAND; lead compound Prevatac enters clinic for sixth indication

Dec. 30, 1998

Water-soluble anticancer compounds available for licensing from NIH

Dec. 30, 1998

Several NDAs up for review by FDA oncologic advisory committee in January

Dec. 30, 1998

Grant to help Faulding and collaborators develop innovative prostate cancer treatment

Dec. 29, 1998

Vion pursues prodrugs of 3-AP with superior biological, pharmaceutical properties

Dec. 29, 1998

Resveratrol shown to bind to and cleave DNA

Dec. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.